131 related articles for article (PubMed ID: 7949094)
1. Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes.
Hafenrichter DG; Wu X; Rettinger SD; Kennedy SC; Flye MW; Ponder KP
Blood; 1994 Nov; 84(10):3394-404. PubMed ID: 7949094
[TBL] [Abstract][Full Text] [Related]
2. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.
Rettinger SD; Kennedy SC; Wu X; Saylors RL; Hafenrichter DG; Flye MW; Ponder KP
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1460-4. PubMed ID: 8108431
[TBL] [Abstract][Full Text] [Related]
3. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.
Okuyama T; Huber RM; Bowling W; Pearline R; Kennedy SC; Flye MW; Ponder KP
Hum Gene Ther; 1996 Mar; 7(5):637-45. PubMed ID: 8845389
[TBL] [Abstract][Full Text] [Related]
4. Liver-directed gene therapy: evaluation of liver specific promoter elements.
Hafenrichter DG; Ponder KP; Rettinger SD; Kennedy SC; Wu X; Saylors RS; Flye MW
J Surg Res; 1994 Jun; 56(6):510-7. PubMed ID: 8015304
[TBL] [Abstract][Full Text] [Related]
5. Retroviral vector sequences may interact with some internal promoters and influence expression.
Wu X; Holschen J; Kennedy SC; Ponder KP
Hum Gene Ther; 1996 Jan; 7(2):159-71. PubMed ID: 8788167
[TBL] [Abstract][Full Text] [Related]
6. Expression of phosphoenolpyruvate carboxykinase (PEPCK) chimeras in renal epithelial cells. Retention of appropriate physiological responsiveness using enhancerless retroviral vectors.
Pollock AS; Lovett DH
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):725-32. PubMed ID: 1377912
[TBL] [Abstract][Full Text] [Related]
7. Hormonal control of interacting promoters introduced into cells by retroviruses.
Hatzoglou M; Bosch F; Park EA; Hanson RW
J Biol Chem; 1991 May; 266(13):8416-25. PubMed ID: 2022656
[TBL] [Abstract][Full Text] [Related]
8. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.
Yee JK; Miyanohara A; LaPorte P; Bouic K; Burns JC; Friedmann T
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9564-8. PubMed ID: 7937806
[TBL] [Abstract][Full Text] [Related]
9. Expression of a liver fatty acid binding protein/human decay-accelerating factor/HLA-B44 chimeric gene in transgenic mice.
Hansbrough JR; Lublin DM; Roth KA; Birkenmeier EA; Gordon JI
Am J Physiol; 1991 Jun; 260(6 Pt 1):G929-39. PubMed ID: 1711781
[TBL] [Abstract][Full Text] [Related]
10. 435-bp liver regulatory sequence in the liver fatty acid binding protein (L-FABP) gene is sufficient to modulate liver regional expression in transgenic zebrafish.
Her GM; Yeh YH; Wu JL
Dev Dyn; 2003 Jul; 227(3):347-56. PubMed ID: 12815620
[TBL] [Abstract][Full Text] [Related]
11. Variables affecting in vivo performance of high-capacity adenovirus vectors.
Schiedner G; Hertel S; Johnston M; Biermann V; Dries V; Kochanek S
J Virol; 2002 Feb; 76(4):1600-9. PubMed ID: 11799154
[TBL] [Abstract][Full Text] [Related]
12. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors.
Pastore L; Morral N; Zhou H; Garcia R; Parks RJ; Kochanek S; Graham FL; Lee B; Beaudet AL
Hum Gene Ther; 1999 Jul; 10(11):1773-81. PubMed ID: 10446917
[TBL] [Abstract][Full Text] [Related]
13. Retroviral vector design for long-term expression in murine hematopoietic cells in vivo.
Correll PH; Colilla S; Karlsson S
Blood; 1994 Sep; 84(6):1812-22. PubMed ID: 8080986
[TBL] [Abstract][Full Text] [Related]
14. Retroviral-mediated gene expression in human myelomonocytic cells: a comparison of hematopoietic cell promoters to viral promoters.
Malik P; Krall WJ; Yu XJ; Zhou C; Kohn DB
Blood; 1995 Oct; 86(8):2993-3005. PubMed ID: 7579392
[TBL] [Abstract][Full Text] [Related]
15. Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors.
Migita M; Medin JA; Pawliuk R; Jacobson S; Nagle JW; Anderson S; Amiri M; Humphries RK; Karlsson S
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12075-9. PubMed ID: 8618847
[TBL] [Abstract][Full Text] [Related]
16. Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo.
Kay MA; Li Q; Liu TJ; Leland F; Toman C; Finegold M; Woo SL
Hum Gene Ther; 1992 Dec; 3(6):641-7. PubMed ID: 1482704
[TBL] [Abstract][Full Text] [Related]
17. Suppressor and activator functions mediated by a repeated heptad sequence in the liver fatty acid-binding protein gene (Fabpl). Effects on renal, small intestinal, and colonic epithelial cell gene expression in transgenic mice.
Simon TC; Cho A; Tso P; Gordon JI
J Biol Chem; 1997 Apr; 272(16):10652-63. PubMed ID: 9099714
[TBL] [Abstract][Full Text] [Related]
18. The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo.
Park F; Ohashi K; Kay MA
Mol Ther; 2003 Aug; 8(2):314-23. PubMed ID: 12907154
[TBL] [Abstract][Full Text] [Related]
19. SREBP-1c and Sp1 interact to regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver.
Chakravarty K; Wu SY; Chiang CM; Samols D; Hanson RW
J Biol Chem; 2004 Apr; 279(15):15385-95. PubMed ID: 14744869
[TBL] [Abstract][Full Text] [Related]
20. Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA.
Aliño SF; Crespo A; Dasí F
Gene Ther; 2003 Sep; 10(19):1672-9. PubMed ID: 12923566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
